As of 2025-11-01, the Relative Valuation of Revive Therapeutics Ltd (RVV.CN) is (0.68) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of Revive Therapeutics Ltd based on Relative Valuation is -4629.6%.
The range of the Relative Valuation is (0.55) - (0.80) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 38.5x - 57.7x | 48.1x |
| Forward P/E multiples | 37.4x - 56.0x | 46.7x |
| Fair Price | (0.55) - (0.80) | (0.68) |
| Upside | -3777.2% - -5455.2% | -4629.6% |
| Date | P/E |
| 2025-10-28 | -1.05 |
| 2025-10-27 | -0.70 |
| 2025-10-24 | -1.05 |
| 2025-10-23 | -0.70 |
| 2025-10-22 | -1.05 |
| 2025-10-21 | -1.05 |
| 2025-10-20 | -1.05 |
| 2025-10-17 | -1.05 |
| 2025-10-16 | -1.05 |
| 2025-10-15 | -1.40 |
| 2025-10-14 | -1.05 |
| 2025-10-10 | -1.05 |
| 2025-10-09 | -0.70 |
| 2025-10-08 | -1.05 |
| 2025-10-07 | -1.05 |
| 2025-10-06 | -1.05 |
| 2025-10-03 | -1.40 |
| 2025-10-02 | -1.05 |
| 2025-10-01 | -0.70 |
| 2025-09-30 | -1.05 |
| 2025-09-29 | -1.05 |
| 2025-09-26 | -1.05 |
| 2025-09-25 | -1.05 |
| 2025-09-24 | -1.05 |
| 2025-09-23 | -1.05 |
| 2025-09-22 | -1.05 |
| 2025-09-19 | -1.05 |
| 2025-09-18 | -1.05 |
| 2025-09-17 | -1.05 |
| 2025-09-16 | -1.40 |
| 2025-09-15 | -1.05 |
| 2025-09-12 | -1.05 |
| 2025-09-11 | -1.40 |
| 2025-09-10 | -1.40 |
| 2025-09-09 | -1.40 |
| 2025-09-08 | -1.05 |
| 2025-09-04 | -1.40 |
| 2025-09-03 | -1.40 |
| 2025-09-02 | -1.40 |
| 2025-08-29 | -1.40 |
| 2025-08-28 | -1.40 |
| 2025-08-27 | -1.05 |
| 2025-08-25 | -1.05 |
| 2025-08-22 | -1.40 |
| 2025-08-21 | -1.22 |
| 2025-08-19 | -1.05 |
| 2025-08-18 | -1.40 |
| 2025-08-15 | -1.40 |
| 2025-08-14 | -1.40 |
| 2025-08-13 | -1.40 |